# The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis

> **NCT00917839** · PHASE2 · UNKNOWN · sponsor: **Cantonal Hospital of St. Gallen** · enrollment: 88 (estimated)

## Conditions studied

- Relapsing-Remitting Multiple Sclerosis

## Interventions

- **DRUG:** lamotrigine

## Key facts

- **NCT ID:** NCT00917839
- **Lead sponsor:** Cantonal Hospital of St. Gallen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2010-12
- **Final completion:** 2011-12
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2009-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00917839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00917839, "The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00917839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*